|
1
|
Weir HK, Thun MJ, Hankey BF, et al: Annual
report to the nation on the status of cancer, 1975–2000, featuring
the uses of surveillance data for cancer prevention and control. J
Natl Cancer Inst. 95:1276–1299. 1998.
|
|
2
|
Tatnell PJ, Powell DJ, Hill J, et al:
Napsins: new human aspartic proteinases. Distinction between two
closely related genes. FEBS Lett. 441:43–48. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chuman Y, Bergman A, Ueno T, et al: Napsin
A, a member of the aspartic protease family, is abundantly
expressed in normal lung and kidney tissue and is expressed in lung
adenocarcinomas. FEBS Lett. 462:129–134. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schauer-Vukasinovic V, Bur D, Kling D, et
al: Human napsin A: expression, immunochemical detection and tissue
localization. FEBS Lett. 462:135–139. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brasch F, Ochs M, Kahne T, et al:
Involvement of napsin A in the C- and N-terminal processing of
surfactant protein B in type-II pneumocytes of the human lung. J
Biol Chem. 278:49006–49014. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ueno T, Linder S and Elmberger G: Aspartic
proteinase napsin is a useful marker for diagnosis of primary lung
adenocarcinoma. Br J Cancer. 88:1229–1233. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hirano T, Gong Y, Yoshida K, et al:
Usefulness of TA02 (napsin A) to distinguish primary lung
adenocarcinoma from metastatic lung adenocarcinoma. Lung Cancer.
41:155–162. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jagirdar J: Application of
immunohistochemistry to the diagnosis of primary and metastatic
carcinoma to the lung. Arch Pathol Lab Med. 132:384–396.
2008.PubMed/NCBI
|
|
9
|
Chang YL, Lee YC, Liao WY, et al: The
utility and limitation of thyroid transcription factor-1 protein in
primary and metastatic pulmonary neoplasms. Lung Cancer.
44:149–157. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hirano T, Franzén B, Uryu K, et al:
Detection of polypeptides associated with the histopathological
differentiation of primary lung carcinoma. Br J Cancer. 72:840–848.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hirano T, Fujioka K, Franzén B, et al:
Relationship between TA01 and TA02 polypeptides associated with
lung adenocarcinoma and histocytological features. Br J Cancer.
75:978–985. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hirano T, Auer G, Maeda M, et al: Human
tissue distribution of TA02, which is homologous with a new type of
aspartic proteinase, napsin A. Jpn J Cancer Res. 91:1015–1021.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suzuki A, Shijubo N, Yamada G, et al:
Napsin A is useful to distinguish primary lung adenocarcinoma from
adenocarcinomas of other organs. Pathol Res Pract. 201:579–586.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ueno T, Linder S, Na CL, et al: Processing
of pulmonary surfactant protein B by napsin and cathepsin H. J Biol
Chem. 279:16178–16184. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ueno T, Elmberger G, Weaver TE, et al: The
aspartic protease napsin A suppresses tumor growth independent of
its catalytic activity. Lab Invest. 88:256–263. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bruno MD, Bohinski RJ, Huelsman KM, et al:
Lung cell-specific expression of the murine surfactant protein A
(SP-A) gene is mediated by interactions between the SP-A promoter
and thyroid transcription factor-1. J Biol Chem. 270:6531–6536.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Barlési F, Pinot D, Legoffic A, et al:
Positive thyroid transcription factor 1 staining strongly
correlates with survival of patients with adenocarcinoma of the
lung. Br J Cancer. 93:450–452. 2005.PubMed/NCBI
|
|
18
|
Berghmans T, Paesmans M, Mascaux C, et al:
Thyroid transcription factor 1 – a new prognostic factor in lung
cancer: a meta-analysis. Ann Oncol. 17:1673–1676. 2006.
|
|
19
|
Tan D, Li Q, Deeb G, et al: Thyroid
transcription factor-1 expression prevalence and its clinical
implications in non-small cell lung cancer: a high-throughput
tissue microarray and immunohistochemistry study. Hum Pathol.
34:597–604. 2003. View Article : Google Scholar
|
|
20
|
Kaufmann O and Dietel M: Expression of
thyroid transcription factor-1 in pulmonary and extrapulmonary
small cell carcinomas and other neuroendocrine carcinomas of
various primary sites. Histopathology. 36:415–420. 2000. View Article : Google Scholar : PubMed/NCBI
|
